不容忽视的马兜铃酸肾病和马兜铃酸的致癌作用(3)
3. Vanhaelen M, Vanhaelen-Fastre R, But P, et al. Identification of aristolochic acid in Chinese herbs. Lancet ，1994,343：174
4. 高瑞通，郑法雷，刘彦信，等. 钙拮抗剂对马兜铃酸Ⅰ所致LLC-PK1细胞凋亡及细胞内钙离子浓度的作用. 肾脏病与透析肾移植杂志，1999,8：6
5. 吴松寒. 木通所致急性肾功能衰竭2例报告. 江苏中医，64，(10)：12
6. 周方钧. 木通中毒1例报告. 白求恩医科大学学报，79，(4)：118
7. 刘金渊，曾汉基. 大量煎服关木通致急性肾功能衰竭死亡1例. 中国中药杂志，19 94，19：692
, http://www.100md.com
8. 周文钧，吕惠文，聂长丰. 木通中毒致急性肾功能衰竭. 中华肾脏病杂志，1988，4：223
9. 叶志斌，崔若蓝. 服木通煎液引起肾脏损害1例. 中国中药杂志，1997,22：570
10. 尹广，胡伟新，黎磊石. 木通中毒的肾脏损害. 肾脏病与透析肾移植杂志，1999，8：15. 15. 15.
11.Depierreux M，Van Damme B，Vanden Houte K，et al. P athologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis, 94，24：172
12. Mengs U, Lang W, Poch JA. The carcinogenic action of aristolochic acid in rats. Arch Toxicol 51: 107-119. 1982.
, 百拇医药
13. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 61: 504-505, 1988
14. Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant. 10: 270-273, 1995
15. Schmeiser HH, Frei E, Wiessler M et al. Comparison of DNA adduct formation by aristolochic acid in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases. Carcinogenesis 18(5): 1055-1062, 1997.
, http://www.100md.com
16. Broschard TH, Wiessler M, Schmeiser HH. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase α.Cancer Letter 98: 47-56, 1995.
17. Stiborova M, Fernando RC, Schmeiser HH et al. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures. Carcinogenesis 15(6): 1187-1192, 1994.
, 百拇医药
18. Stiborova M, Frei E, Breuer A. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxic Pathol 51: 421-427, 1999.
19. Fernando RC, Schmeiser HH, Scherf HR et al. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I, in Phillips DH, Castegnaro M, Bartsch H (eds): Postlabelling methods for Detection of DNA Adducts. Lyon, France, International Agency for Research on Cancer, 1993, pp 167-171.1999，8：10, http://www.100md.com(陈文)
4. 高瑞通，郑法雷，刘彦信，等. 钙拮抗剂对马兜铃酸Ⅰ所致LLC-PK1细胞凋亡及细胞内钙离子浓度的作用. 肾脏病与透析肾移植杂志，1999,8：6
5. 吴松寒. 木通所致急性肾功能衰竭2例报告. 江苏中医，64，(10)：12
6. 周方钧. 木通中毒1例报告. 白求恩医科大学学报，79，(4)：118
7. 刘金渊，曾汉基. 大量煎服关木通致急性肾功能衰竭死亡1例. 中国中药杂志，19 94，19：692
, http://www.100md.com
8. 周文钧，吕惠文，聂长丰. 木通中毒致急性肾功能衰竭. 中华肾脏病杂志，1988，4：223
9. 叶志斌，崔若蓝. 服木通煎液引起肾脏损害1例. 中国中药杂志，1997,22：570
10. 尹广，胡伟新，黎磊石. 木通中毒的肾脏损害. 肾脏病与透析肾移植杂志，1999，8：15. 15. 15.
11.Depierreux M，Van Damme B，Vanden Houte K，et al. P athologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis, 94，24：172
12. Mengs U, Lang W, Poch JA. The carcinogenic action of aristolochic acid in rats. Arch Toxicol 51: 107-119. 1982.
, 百拇医药
13. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 61: 504-505, 1988
14. Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant. 10: 270-273, 1995
15. Schmeiser HH, Frei E, Wiessler M et al. Comparison of DNA adduct formation by aristolochic acid in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases. Carcinogenesis 18(5): 1055-1062, 1997.
, http://www.100md.com
16. Broschard TH, Wiessler M, Schmeiser HH. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase α.Cancer Letter 98: 47-56, 1995.
17. Stiborova M, Fernando RC, Schmeiser HH et al. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures. Carcinogenesis 15(6): 1187-1192, 1994.
, 百拇医药
18. Stiborova M, Frei E, Breuer A. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxic Pathol 51: 421-427, 1999.
19. Fernando RC, Schmeiser HH, Scherf HR et al. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I, in Phillips DH, Castegnaro M, Bartsch H (eds): Postlabelling methods for Detection of DNA Adducts. Lyon, France, International Agency for Research on Cancer, 1993, pp 167-171.1999，8：10, http://www.100md.com(陈文)